DeutschNewstral
Article
jdsupra.com on 2016-02-18 01:04
SEC Charges U.S. Pharmaceutical Company for FCPA Violations Arising from Alleged Bribery in China
Related news
- SEC Reaches $8.8 Million Settlement With Pharmaceutical Company To Resolve Allegations Of FCPA Violationsjdsupra.com
- California-Based Pharmaceutical Company Settles with SEC Regarding FCPA Offenses in Chinajdsupra.com
- ENI Pays SEC $24.5 for FCPA Violationsjdsupra.com
- Alert: "DOJ And SEC Reach Settlement With Walmart For FCPA Violations"jdsupra.com
- SEC Charges Australian Mining Company for FCPA Violations Arising from Its Hospitality Program at the 2008 Beijing Olympicsjdsupra.com
- Ericsson to Pay Over $1 Billion to Settle FCPA Bribery Violations with DOJ and SECjdsupra.com
- Beam Settles FCPA Violations with SEC for $8 Million for Pervasive Third-Party Bribery Schemesjdsupra.com
- FCPA: Anti-Bribery Provisionsjdsupra.com
- Landmark SEC Decision Cites Compliance, Diligence in Decision Not to Prosecute FCPA Violationsjdsupra.com
- SEC Highlights Model Response to Evidence of FCPA Violations, Announces Non-Prosecution Agreementsjdsupra.com
- MStryker to pay $7.8 million fine to SEC for FCPA violationsmarketwatch.com
- [Audio] Episode 296 -- Deep Dive into Clear Channels SEC Settlement of FCPA Violationsjdsupra.com
- SEC Fines International Conglomerate $6.5 Million For FCPA Violations Related To Client Travel And Hospitality Expensesjdsupra.com
- Novartis Coughs Up $25 Million to SEC for China FCPA Violationsjdsupra.com
- MSEC fines Kinross Gold over FCPA violationsmarketwatch.com
- China, FCPA, and SECjdsupra.com
- TechnipFMC FCPA Enforcement Action: Part 2 – The Bribery Schemesjdsupra.com
- Travel, Entertainment, Gifts Yield DOJ, SEC FCPA Charges Againjdsupra.com
- Securities and Exchange Commission (SEC) Emphasizes Priority to Bring Enforcement Actions for Commercial Bribery under U.S. Foreign Corrupt Practices Act (FCPA)jdsupra.com
- Tenaris Pays SEC $78 Million to Resolve FCPA Violationsjdsupra.com